Sanofi Pasteur Announces Results of U.S. Clinical Trials of Influenza A (H1N1) Vaccine in Infants an...(ended December 31 2008. Other than as re...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Sanofi Pasteur Announces Results of U.S. Clinical Trials of Influenza A (H1N1) Vaccine in Infants and Children
Date:10/14/2009
ended December 31, 2008. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any forward-looking information or statements.
Contact
US Media Relations
Donna Cary
T. +1-570-957-0717
donna.cary@sanofipasteur.com
www.sanofipasteur.us
SOURCE Sanofi Pasteur
'/>"/>
| SOURCE Sanofi Pasteur Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
5. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
6. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
7. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
8. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
9. Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
10. Sanofi-aventis Stands Behind the Safety of Lantus(R)
11. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
Post Your Comments:
(Date:12/16/2009)... WORTH, Texas, Dec. 16 Wound ... a rapidly growing provider of specialty medical ... operating subsidiary is moving toward productization of ... The company currently anticipates products to be ... market, estimated to be a multi-billion dollar ...
(Date:12/16/2009)... Inc. (OTC Bulletin Board: HEWA) an online U.S. mail-order ... 12% per annum short term debt financing. The ... of $500,000, with accrued interest and principal repayable in ... interest and principal repayable in one year from its ... for any calendar month prior to December 15, 2010. ...
(Date:12/16/2009)... International, well-known,scientific experts were ... (80 mg/day),data presented as "extremely promising."[1] ... and clinicians critically reviewed these data.,These ... generic lipid-modifying,treatments, fenofibrate and bezafibrate, in ... in patients with metabolic syndrome,and type ...
Breaking Medicine Technology:Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3iSirona Announces Go live at University Hospitals in Cleveland 14887 1iSirona Announces Go live at University Hospitals in Cleveland 14887 2iSirona Announces Go live at University Hospitals in Cleveland 14887 3AMA Optics Announces New Brightness Acuity Meter Documents Disabling Glare from Cataract 61591 1AMA Optics Announces New Brightness Acuity Meter Documents Disabling Glare from Cataract 61591 2Deduplication Trend Eases the Strain of Medical Records Storage 61586 1Deduplication Trend Eases the Strain of Medical Records Storage 61586 2[0] Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics[0] HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing[0] International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia
... WIRE)--Apr 19, 2007 - Antares Pharma, Inc.,(AMEX: ... completed,site application study demonstrating that ANTUROL(R), it's,oxybutynin ... bioequivalent,basis after a single-dose was applied to ... an open-label, comparative three-way crossover,application site pharmacokinetic ...
... AACR Highlight Progress in SuperGen's,Oncology-Focused Pre-Clinical Pipeline, ... SuperGen,Inc. today announced that MP470, its multi-targeted ... critical component of,double- stranded DNA repair in ... of,presentations at the 2007 American Association for ...
Other Medicine Technology:Antares Pharma Announces Positive Results from Application Site,Study for Anturol 2Antares Pharma Announces Positive Results from Application Site,Study for Anturol 3Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 2Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 3Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 4Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 5Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 6Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 7(Date:12/16/2009)... Raises Significant Funds to Benefit of Children with Autism ... Taylor, Gary Cole and Zachary Levi Join Ben Stiller ... ANGELES, Dec. 16 At its 13th annual ... individuals. Hasbro President & CEO Brian ... in recognition of his far-reaching philanthropic leadership and commitment ...
(Date:12/16/2009)... -- Every year in the United States, 160,000 cases ... of the disease, making it the second leading cause ... , As researchers and clinicians fervently look for causes ... of studies producing more and more promising results ... genetics at Case Western Reserve University School of Medicine ...
(Date:12/16/2009)... Immucor, Inc. (Nasdaq: BLUD ), a global leader ... industry, today announced that Paul D. Mintz, M.D. has ... director, effective January 1, 2010. ,, Dr. Mintz ... for more than 30 years. He is a tenured ... Virginia School of Medicine. He also serves as director ...
(Date:12/16/2009)... Allscripts (Nasdaq: MDRX ) announced today that ... three and six months ended November 30, 2009 ... 11, 2010. Allscripts management will host a conference ... and other information at 8:30 AM Eastern Standard ... http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, Allscripts fiscal second quarter earnings ...
(Date:12/16/2009)... widely used human embryonic stem cell lines lack genetic ... must be addressed to ensure that all sectors of ... University of Michigan research team. ,, In the first ... 47 embryonic stem cell lines, including most of the ... determined the genetic ancestry of each line and found ...
Breaking Medicine News(10 mins):Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3Health News:Immucor Appoints New Board Director 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5[0] The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests[0] New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer'[1] Immucor Appoints New Board Director[0] Allscripts to Announce Second Quarter Fiscal 2010 Results[0] U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines
... tumor disease has affected the ecological balance existing between native ... disease the number of devils has sharply reduced. David Pemberton ... the devil population in the Mt William National Park. ... see carcasses lying around the area. Wedge-tailed eagles are feeding ...
... research done by Dr Allan Pantuck it was found that ... , Prostate cancer is the most common cancer affecting men ... each year and about 10,000 die from the disease. ... presence of prostate cancer. But study shows that consumption of ...
... has revealed that having several older brothers increases the chances ... adds //weight to the idea of a biological basis for ... University in St Catharines, Canada said, "It's likely to be ... is probably a biological basis for homosexuality." ,S ...
... be associated with reduced length of antibiotic treatment for ... ,A biomarker of infection, procalcitonin appeared to ... therapy as compared with other parameters. ,The ... kind, appears in the first issue for July 2006 ...
... August, and Uganda will have one more problem to surmount ... stock of free antiretroviral//. Soon, Uganda will be left with ... grips of disease. ,The stock is said to ... ups will not have enough to tide over the next ...
... from Laval University, Quebec say that chronic job stress ... white-collar workers. // ,The research, appearing in the ... levels and tight deadlines increased blood pressure especially in ... seven years. "Our study supports the hypothesis that job ...
Other Medicine News:Health News:Procalcitonin-Guided Antibiotic Therapy Proved Effective in CAP Cure 2Health News:Procalcitonin-Guided Antibiotic Therapy Proved Effective in CAP Cure 3Tasmanian Ecology Affected By Devil Facial Tumor DiseasePomegranate Juice Remedy for Prostate CancerBiological Basis for HomosexualityProcalcitonin-Guided Antibiotic Therapy Proved Effective in CAP CureDepleting stock of antiretroviral drugs in Uganda raises concernStress At Job Adversely Affects Blood Pressure
Corning 7078 Calibrated"to deliver". multi-pack plugged capacity 5 mL...
... operative hysteroscopy, the surgeon and O.R. staff ... the dangers of fluid intravasation. Manual methods ... solution is the DOLPHIN II Fluid Management ... market leader in endoscopic irrigation. It has ...
... precision 4mL PYREX volumetric pipets ... Contain" (TC - bottom line) ... top line) to specifications for ... are color-coded with colored graduations ...
1000L...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |